DBC vs IBB
Invesco DB Commodity Index Tracking Fund vs iShares Biotechnology ETF
DBC$30.25
Invesco DB Commodity Index Tracking Fund
Diversified commodity basket.
Expense: 0.85%Yield: 2.40%
IBB$170.10
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: 0.44%Yield: 0.23%
Quick take
- • IBB has the lower expense ratio at 0.44% vs 0.85% for DBC.
- • DBC pays a higher dividend yield (2.40%).
Side-by-side metrics
| Metric | DBC | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.85% | 0.44% |
Dividend yield Trailing 12-month yield. | 2.40% | 0.23% |
AUM Assets under management — bigger funds are typically more liquid. | $1.89B | $7.95B |
YTD return | 35.11% | 3.10% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.02 | 0.74 |
P/E ratio | 7.32 | 23.72 |
Last price | $30.25 | $170.10 |
Inception | — | — |
Issuer | Invesco | iShares |
DBC top holdings
Top holdings · DBC
| AGPXX | Invesco Shrt-Trm Inv Gov&Agcy Instl | 41.56% |
| BRNU26 | Brent Crude Future July 26 | 9.67% |
| TBLL | Invesco Short Term Treasury ETF | 6.02% |
IBB top holdings
Top holdings · IBB
| AMGN | Amgen Inc | 7.37% |
| GILD | Gilead Sciences Inc | 7.32% |
| VRTX | Vertex Pharmaceuticals Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 6.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.71% |
| ARGX | argenx SE ADR | 3.33% |
| INSM | Insmed Inc | 2.70% |
| BIIB | Biogen Inc | 2.67% |
| NTRA | Natera Inc | 2.40% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.27% |
Sector breakdown · IBB
Healthcare100.0%
About DBC
DBC (Invesco DB Commodity Index Tracking Fund) is Diversified commodity basket. Managed by Invesco, the fund carries $1.9B in assets under management, an expense ratio of 0.85%, a dividend yield of 2.40%. Its largest holding is Invesco Shrt-Trm Inv Gov&Agcy Instl (AGPXX), which represents 41.6% of the portfolio.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.